Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics

Miami, Florida 33136

3 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Biliary Tract Cancer, Grade 2 Glioma, Hepatocellular Carcinoma, High-risk Myelodysplastic Syndrome, Non-muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Recurrent Glioma, Relapsed/Refractory Multiple Myeloma, Residual Glioma, Superficial Bladder Cancer

Studies at this site

• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
• Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC — Recruiting now
• CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma — Recruiting now
• Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) — Running, not enrolling
• RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome — Status unconfirmed